0.685
Aclarion Inc stock is traded at $0.685, with a volume of 3.50M.
It is down -15.94% in the last 24 hours and down -85.52% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$0.8149
Open:
$0.7471
24h Volume:
3.50M
Relative Volume:
0.10
Market Cap:
$695.88K
Revenue:
$49,300
Net Income/Loss:
$-6.27M
P/E Ratio:
-0.0754
EPS:
-9.09
Net Cash Flow:
$-5.38M
1W Performance:
-57.19%
1M Performance:
-85.52%
6M Performance:
+260.53%
1Y Performance:
+90.81%
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ACON
Aclarion Inc
|
0.685 | 695.88K | 49,300 | -6.27M | -5.38M | -9.09 |
![]()
VEEV
Veeva Systems Inc
|
227.80 | 36.98B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
SOLV
Solventum Corp
|
72.30 | 12.51B | 8.26B | 66.00M | 1.17B | 0.3682 |
![]()
DOCS
Doximity Inc
|
60.80 | 11.41B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
HQY
Healthequity Inc
|
93.97 | 8.14B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
TEM
Tempus Ai Inc
|
42.16 | 7.26B | 640.44M | -743.28M | -206.93M | -11.29 |
Aclarion Inc Stock (ACON) Latest News
Aclarion provides shareholder update, to file 10K by March-end -March 13, 2025 at 11:00 am EDT - Marketscreener.com
Aclarion, Inc. secures compliance with Nasdaq equity rule - Investing.com
Aclarion Provides Shareholder Update - The Manila Times
Aclarion Sets Major Corporate Update: 8-K Filed, 10-K Coming for AI Healthcare Pioneer - StockTitan
Aclarion announces expansion plans with RadNet affiliates in NY, NJ - MSN
Aclarion, a company using remote MRIs to assess back pain, expands in partnership with RadNet - Radiology Business
United States shares lower at close of trade; Dow Jones Industrial Average down 0.99% - Investing.com India
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.99% - Investing.com
Aclarion expands Nociscan access in New York, New Jersey - AuntMinnie
Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey - The Globe and Mail
Aclarion to Expand Nociscan Access in New York, New Jersey -March 06, 2025 at 12:00 pm EST - Marketscreener.com
Aclarion Announces Expansion Plans With RadNet Affiliates In New York And New Jersey - Marketscreener.com
Aclarion stock hits 52-week low at $2.26 amid sharp annual decline - Investing.com Australia
Aclarion expands Nociscan sites in New York, New Jersey - Investing.com India
Aclarion shareholders approve stock issuance and charter amendment - Investing.com India
Dow Tumbles 1%; US Initial Jobless Claims Decline - Benzinga
Aclarion expands Nociscan sites in New York, New Jersey By Investing.com - Investing.com UK
Aclarion, Inc. Announces Expansion of Nociscan Access in New York and New Jersey to Address Chronic Low Back Pain - Nasdaq
Can This 97% Effective Spine Technology Transform RadNet's 112 Medical Centers? - StockTitan
Aclarion shareholders approve stock issuance and charter amendment By Investing.com - Investing.com UK
Is Aclarion's Tie-Up With Scripps Health A Lasting Catalyst? Most Retail Traders Think It's A 'Game-Changer' - Asianet Newsable
The amazing story behind Aclarion’s 126% stock surge and future prospects - Dataconomy
Aclarion Partners with Scripps Health to Bring Chronic Low Back Pain Solution to Southern California - HIT Consultant
Aclarion Expands Nociscan to Scripps Health, Advancing Chronic Low Back Pain Diagnostics in Southern California - Apna Kal
Why Aclarion (ACON) Shares Are Skyrocketing - Benzinga
Aclarion (NASDAQ: ACON) Soars on Scripps Health Partnership, Expanding Nociscan's Reach - Apna Kal
Aclarion to Provide Imaging Technology to Scripps Health in California; Shares Jump -March 03, 2025 at 09:33 am EST - Marketscreener.com
Why Is Healthcare Technology Company Aclarion Stock Rocketing Premarket On Monday? - Benzinga India
Aclarion (ACON) Shares Surge In Pre-Hour Trading Amid Key Healthcare Deal - Stocks Telegraph
Aclarion rises on commercial agreement with Scripps Health - TradingView
Aclarion Expands Access to Nociscan Technology Through Agreement with Scripps Health in San Diego Area - Nasdaq
Aclarion Announces First Commercial Agreement with Scripps Health - The Manila Times
How Aclarion's New Scripps Health Deal Could Transform Chronic Back Pain Diagnosis - StockTitan
LGVN To Complete ELPIS II Enrollment By Q2, Time To Keep An Eye On NXGL, What's The Buzz At ACON? - RTTNews
Aclarion, Inc. (NASDAQ:ACON) Short Interest Up 1,730.4% in February - Defense World
Aclarion, Inc. Adjourns Special Meeting for More Votes - TipRanks
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders - The Manila Times
Aclarion Postpones Critical Stockholder VoteWill March 5 Meeting Secure Enough Support? - StockTitan
Aclarion stock hits 52-week low at $3.82 amid sharp annual decline - Investing.com Canada
Aclarion stock hits 52-week low at $3.82 amid sharp annual decline By Investing.com - Investing.com South Africa
(ACON) Technical Data - Stock Traders Daily
Aclarion, Inc. (ACON) to Showcase NOCISCAN’s Impact on Spine Surgery at 2025 Spine Summit - Yahoo Finance
Top 8 Must-See AI News Updates Investors Probably Missed - Insider Monkey
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit - EIN News
Aclarion Showcases NOCISCAN's Innovative Role in Chronic Low Back Pain Management at 2025 Spine Summit, Led by Dr. Nicholas Theodore - Nasdaq
Can This AI-Powered Technology Finally Solve the $300B Chronic Back Pain Crisis? - StockTitan
Aclarion secures patent for infection, pain biomarker detection - MSN
Short Interest in Aclarion, Inc. (NASDAQ:ACON) Decreases By 99.8% - Defense World
Aclarion receives U.S. patent on expanded applications of MRS data processing - MSN
Aclarion stock hits 52-week low at $4.41 amid steep annual decline - MSN
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):